Atlas Trials

An Open-Label, Single and Multiple Dose Pharmacokinetic Study of 90 mg and 180 mg Doses of AZD6140 in Healthy Volunteers

Clinical trial NCT00721448 · COMPLETED

Trial details

NCT number
NCT00721448
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2008-06-01
Primary completion
2008-08-01
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.